Philips and WellSpan Forge AI-Powered Healthcare Alliance
AMSTERDAM, Netherlands and YORK, Pa., June 4, 2026 Royal Philips and WellSpan Health have announced a landmark seven-year strategic...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
AMSTERDAM, Netherlands and YORK, Pa., June 4, 2026 Royal Philips and WellSpan Health have announced a landmark seven-year strategic...
CHICAGO, April 15, 2026 AIRS Medical has announced that its SwiftMR® AI-powered MRI image enhancement solution has received FDA...
